50 Healthcare Stocks Moving In Friday's Pre-Market Session

Gainers

  • Dynatronics, Inc. DYNT shares increased by 239.4% to $4.09 during Friday's pre-market session.
  • Ritter Pharmaceuticals, Inc. RTTR shares rose 182.0% to $0.80.
  • Altimmune, Inc. ALT shares surged 110.8% to $3.71.
  • Allied Healthcare Prods, Inc. AHPI stock increased by 91.4% to $29.70.
  • Trinity Biotech, Inc. TRIB shares rose 58.9% to $1.70.
  • Correvio Pharma, Inc. CORV shares moved upwards by 53.4% to $0.47. According to the most recent rating by H.C. Wainwright, on December 11, the current rating is at Neutral.
  • Guardion Health Sciences, Inc. GHSI stock surged 46.5% to $0.69.
  • Trillium Therapeutics, Inc. TRIL shares surged 41.9% to $4.40.
  • BOQI International, Inc. BIMI shares rose 39.8% to $5.90.
  • Vaxart, Inc. VXRT stock surged 38.5% to $3.42.
  • Verastem, Inc. VSTM stock moved upwards by 35.6% to $2.59.
  • OpGen, Inc. OPGN stock rose 29.9% to $2.65.
  • Sangamo Therapeutics, Inc. SGMO stock increased by 29.8% to $8.65.
  • Titan Pharmaceuticals, Inc. TTNP shares increased by 29.0% to $0.27.
  • Novavax, Inc. NVAX stock moved upwards by 26.7% to $14.95. The most recent rating by B. Riley FBR, on February 28, is at Buy, with a price target of $16.00.
  • Co-Diagnostics, Inc. CODX stock surged 23.4% to $19.70. The most recent rating by HC Wainwright & Co., on February 24, is at Buy, with a price target of $4.00.
  • Forty Seven, Inc. FTSV shares surged 23.0% to $60.00. The most recent rating by Mizuho, on February 12, is at Buy, with a price target of $53.00.
  • Vir Biotechnology, Inc. VIR stock rose 21.6% to $73.19. The most recent rating by JP Morgan, on February 04, is at Neutral, with a price target of $26.00.
  • China SXT Pharmaceuticals, Inc. SXTC stock surged 20.6% to $1.23.
  • Assertio Therapeutics, Inc. ASRT shares moved upwards by 19.1% to $1.25.
  • Lianluo Smart, Inc. LLIT shares moved upwards by 18.4% to $0.91.
  • Beyond Air, Inc. XAIR shares surged 18.3% to $8.65.
  • Cocrystal Pharma, Inc. COCP shares surged 17.2% to $1.50.
  • Meridian Bioscience, Inc. VIVO shares increased by 13.4% to $9.25.
  • Happiness Biotech, Inc. HAPP shares surged 13.3% to $5.86.

 

Losers

  • Novan, Inc. NOVN stock plummeted 35.3% to $0.22 during Friday's pre-market session. The most recent rating by H.C. Wainwright, on January 06, is at Buy, with a price target of $1.50.
  • Diffusion Pharmaceuticals, Inc. DFFN stock decreased by 13.0% to $0.31. The most recent rating by H.C. Wainwright, on December 18, is at Buy, with a price target of $3.50.
  • PAVmed, Inc. PAVM shares decreased by 11.2% to $2.15.
  • Kadmon Holdings, Inc. KDMN stock plummeted 10.3% to $4.00. The most recent rating by Nomura Instinet, on January 10, is at Buy, with a price target of $10.00.
  • Acasti Pharma, Inc. ACST shares plummeted 9.8% to $0.40. The most recent rating by H.C. Wainwright, on February 18, is at Buy, with a price target of $3.00.
  • Moderna, Inc. MRNA stock fell 8.8% to $23.86. The most recent rating by Needham, on February 26, is at Buy, with a price target of $35.00.
  • Viveve Medical, Inc. VIVE stock plummeted 8.5% to $1.08. According to the most recent rating by Ladenburg Thalmann, on December 03, the current rating is at Buy.
  • Five Prime Therapeutics, Inc. FPRX stock plummeted 7.4% to $4.00. According to the most recent rating by JP Morgan, on February 28, the current rating is at Underweight.
  • Celldex Therapeutics, Inc. CLDX shares plummeted 7.4% to $2.51. The most recent rating by Cantor Fitzgerald, on February 21, is at Overweight, with a price target of $8.00.
  • Zosano Pharma, Inc. ZSAN stock declined 7.2% to $0.65.
  • Genprex, Inc. GNPX stock fell 7.0% to $4.35.
  • Advaxis, Inc. ADXS shares fell 7.0% to $0.72.
  • Onconova Therapeutics, Inc. ONTX stock decreased by 6.4% to $0.44.
  • Cyclacel Pharmaceuticals, Inc. CYCC stock declined 6.4% to $0.52.
  • CHF Solutions, Inc. CHFS shares fell 6.3% to $0.32.
  • NantKwest, Inc. NK stock plummeted 6.2% to $4.39.
  • Nabriva Therapeutics, Inc. NBRV stock fell 6.2% to $1.21.
  • argenx, Inc. ARGX stock plummeted 6.0% to $135.00. According to the most recent rating by B of A Securities, on February 10, the current rating is at Buy.
  • Heat Biologics, Inc. HTBX stock declined 5.7% to $0.20. The most recent rating by Maxim Group, on February 06, is at Buy, with a price target of $1.00.
  • Achieve Life Sciences, Inc. ACHV shares fell 5.6% to $0.44. The most recent rating by H.C. Wainwright, on February 25, is at Buy, with a price target of $2.00.
  • OrganiGram Holdings, Inc. OGI shares plummeted 5.4% to $2.10. According to the most recent rating by Raymond James, on January 09, the current rating is at Market Perform.
  • Amarin Corp, Inc. AMRN shares decreased by 5.2% to $13.90. The most recent rating by Oppenheimer, on February 26, is at Underperform, with a price target of $12.00.
  • Agile Therapeutics, Inc. AGRX shares fell 5.1% to $2.60. The most recent rating by H.C. Wainwright, on February 18, is at Buy, with a price target of $7.00.
  • Grifols, Inc. GRFS stock plummeted 5.0% to $22.30.
  • TherapeuticsMD, Inc. TXMD shares decreased by 4.8% to $1.58. The most recent rating by H.C. Wainwright, on February 21, is at Buy, with a price target of $6.00.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Pre-Market OutlookMarketsMoversTrading IdeasHealth CareHealthcare Stocks Pre-Market MoversPharmaceuticalsTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!